In the current study, we report the first case of a TOR1AIP2::ETV6 fusion in a patient with AML that progressed from MDS using targeted RNA-seq, underlining its application in the identification of minor chromosomal variations with elevated sensitivity in spite of the karyotype analysis showing a normal karyotype. The gene discussed is TOR1AIP2; the disease is acute myeloid leukemia.